Amanote Research
Register
Sign In
PUB047 Efficacy of EGFR-TKI for Lung Adenosquamous Cell Carcinoma Harboring EGFR Mutation
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2017.09.1910
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
November 1, 2017
Authors
Y. Liu
X. Xia
W. Du
Y. Zhang
J. Xu
Y. Gong
J. Zhu
Z. Ding
F. Peng
M. Huang
Y. Xu
J. Wan
L. Ren
Y. Lu
B. Han
Y. Wang
Publisher
Elsevier BV
Related search
EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma
Annals of Surgical Oncology
Oncology
Surgery
Reply to “EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma”
Annals of Surgical Oncology
Oncology
Surgery
Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Molecular Cancer Therapeutics
Cancer Research
Oncology
Post-Progression Survival After EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
PLoS ONE
Multidisciplinary
Gefitinib for a Poor Performance Status Patient With Squamous Cell Carcinoma of the Lung Harboring EGFR Mutation
Internal Medicine
Internal Medicine
Medicine
Acquired EGFR C797S Mutation Mediates Resistance to AZD9291 in Non–small Cell Lung Cancer Harboring EGFR T790M
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
Expert Review of Anticancer Therapy
Oncology
Pharmacology
P1.01-25 Carboplatin and Pemetrexed Plus Bevacizumab After Failure of First-Line EGFR-TKI Therapy for NSCLC Harboring EGFR Mutation (CJLSG 0908)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary